Viral Vaccines Clinical Trial
Official title:
Influenza Vaccine Responses in the Setting of Melanoma Treatment
Influenza vaccination is indicated for all adults, but the immunogenicity of vaccination has not been assessed in all situations. We are conducting a prospective unblinded study of influenza vaccine recipients.
Influenza vaccination is indicated for all adults, but the immunogenicity of vaccination has not been assessed in all situations. In particular, immune responses following influenza vaccination have not been studied in the setting of advanced melanoma and in the context of various anti-tumor treatments. In this study, we will look at the immune response of subjects receiving vaccination. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT01489358 -
Chikungunya Virus Vaccine Trial in Healthy Adults
|
Phase 1 |